SCHEMBL4744551

SCHEMBL4744551

O=C(O)Oc1ccc(CC(=O)c2cccnc2)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 8/20 0.53
PLOD2 O00469 1/20 0.53
LMNA P02545 4/20 0.50
ATM Q13315 1/20 0.50
ALDH1A1 P00352 4/20 0.48
CYP1A2 P05177 1/20 0.48
CYP2C9 P11712 1/20 0.48
TSHR P16473 1/20 0.48
CYP2C19 P33261 1/20 0.48
MAPT P10636 3/20 0.48
KDM4E B2RXH2 2/20 0.48
APP P05067 1/20 0.47
GAA P10253 1/20 0.47
HCAR3 P49019 1/20 0.47
HCAR2 Q8TDS4 1/20 0.47
THRB P10828 2/20 0.47
TDP1 Q9NUW8 1/20 0.47
HTT P42858 1/20 0.46
CYP3A4 P08684 1/20 0.46
RAB9A P51151 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4744549 0.90 KMT2A (0.54) KMT2APLOD2LMNAATMALDH1A1
SCHEMBL31326709 0.84 KDM4E (0.64) KMT2APLOD2LMNAALDH1A1MAPT
SCHEMBL10664827 0.84 KDM4E (0.64) KMT2APLOD2LMNAALDH1A1MAPT
SCHEMBL9310930 0.83 PLOD2 (0.50) KMT2APLOD2LMNAALDH1A1CYP1A2
SCHEMBL360711 0.83 PLOD2 (0.69) KMT2APLOD2LMNAALDH1A1TSHR
SCHEMBL6501915 0.82 RAB9A (0.66) KMT2APLOD2LMNAALDH1A1MAPT
SCHEMBL4745216 0.82 THRB (0.50) KMT2APLOD2LMNAATMALDH1A1
Bromide SCHEMBL11040809 0.82 PLOD2 (0.67) KMT2APLOD2LMNAALDH1A1TSHR
Hydrochloric Acid SCHEMBL11169565 0.82 PLOD2 (0.67) KMT2APLOD2LMNAALDH1A1TSHR
SCHEMBL4744539 0.80 PLOD2 (0.56) KMT2APLOD2LMNAALDH1A1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008115141-A1 4, 5-DIHYDRO-1,3-THIAZOL-2-AMINE DERIVATIVES AND THEIR USE IN THE TREATMENT OF RESPIRATORY, CARDIOVASCULAR, NEUROLOGICAL OR GASTROINTESTINAL DISORDERS ALBIREO AB (SE) 2008-09-25 WO disclosed